Lenzing's €600m Question: Can a Doubled Profit Mask the Cost of Reinvention?
Published on 08/08/2026 at 04:12 | Redaktion boerse-global.de
The arithmetic at Lenzing is starting to look contradictory. Net income for the first half of 2026 more than doubled to €35.6 million from €15.2 million a year earlier, yet revenue slipped to €1.27 billion from €1.34 billion and EBITDA margin compressed from 20 percent to 18.9 percent. A casual glance at the bottom line suggests a company on the mend. A closer look reveals something else entirely: a fibre maker in the middle of its most disruptive overhaul in years, where the headline profit figure owes more to one-off effects than to any fundamental improvement in the core business.
The Price of Reshaping
That divergence explains why management has signed off on a restructuring that carries a heavy near-term cost. The fibre production site at Heiligenkreuz in Austria's Burgenland region will cease output by the end of 2026, with a buyer already being sought. The Grimsby facility in the UK is also being wound down, with its exit expected by the end of 2027. Meanwhile, a disposal process for the Indonesian production site has been running since September 2025, with job cuts in that market scheduled for the third quarter.
The balance sheet impact is substantial. Lenzing anticipates impairments of up to €150 million on long-term assets in 2026 — charges that will hit EBIT and net income, though not EBITDA. Restructuring provisions of up to €40 million are also expected, and these will weigh on EBITDA directly. The workforce, which stood at roughly 8,100 employees globally, is set to shrink by around 2,000 positions by the end of 2027, including 600 in administrative roles. Management has framed the programme as a performance drive targeting €120 million in savings against 2025 baseline levels, with full effect only arriving towards the end of 2027.
A Strategic Pivot With an Identity Question
Underpinning the cuts is a new strategic direction dubbed "Grow Nonwovens, Reset Textiles." The share of revenue derived from the traditional textile business is slated to fall from 45 percent to roughly 30 percent over the medium term, while nonwovens and pulp are each expected to rise to around 30 percent. That represents a deliberate shift towards hygiene products and next-generation fibres — and raises an open question about whether a company with deep roots in textile fibres can reinvent itself as a nonwovens specialist without losing its core identity.
Restructuring of this scale brings inevitable disruption — including for UK operations like the Grimsby site. When workplaces change, safety documentation often falls behind. A free toolkit with 41 ready-to-use templates and checklists helps you keep risk assessments current through periods of transition. Download the free Risk Assessment Toolkit
The second quarter offered some encouragement. Revenue climbed to €651.7 million from €615.7 million in the first quarter, supported by targeted price increases. Free cash flow improved to €45.8 million, and EBITDA came in at €239.2 million. But these figures sit alongside the reality of a business that earns less from its core operations than it once did — a structural trend that the doubled net profit does little to dispel.
The August 25 Test
Transformation of this scale requires capital, and Lenzing has assembled a refinancing package that brings up to €600 million in new credit lines while extending existing debt maturities to 2030. An extraordinary general meeting has been called for August 25 to approve a capital injection of up to €600 million, of which as much as €300 million would come from shareholders through a rights issue. The core shareholder syndicate — B&C Group, Brazilian pulp producer Suzano, and Oberbank — has indicated it will participate in line with its respective stakes. That commitment from the anchor investors is reassuring, but it also places a burden on minority holders who wish to maintain their positions.
The share price has already registered its discomfort. On the most recent trading day, the stock fell 2.85 percent to close at €23.85, leaving it roughly 20 percent below its 52-week high of €29.75. The shares are trading just under their 200-day moving average — a technical signal that reflects how much market confidence has eroded since the spring.
A CEO Putting His Money Where His Strategy Is
In a move that carries symbolic weight ahead of the capital increase, chief executive Georg Kasperkovitz — who stepped up from chief operating officer to the top role on June 1, succeeding Rohit Aggarwal — has reportedly purchased 18,180 Lenzing shares at €27.63 apiece, an outlay of just over half a million euros. A CEO buying personal equity shortly before a major capital raise sends a message that no investor presentation can replicate.
The market has taken some notice. In mid-June, Berenberg upgraded the stock from Hold to Buy, lifting its price target from €24 to €29.50 — a call made well before the current capital increase was announced.
There is also political backing for one of the affected sites. Burgenland governor Hans Peter Doskozil has reportedly thrown his support behind the search for an investor in Heiligenkreuz and has not ruled out a state stake in the facility should closure otherwise loom. That provides some comfort, though it is no guarantee of a successful sale.
With major industrial transitions underway across Europe, UK employers face their own compliance pressures. Over 37,000 British companies already use a free toolkit covering COSHH, fire safety and general risk assessments to stay compliant with current regulations. Get the free Health & Safety Toolkit
Open Questions
The coming weeks around the August 25 meeting will determine whether shareholders are willing to fund the turnaround — or whether the capital increase becomes another point of strain. The operational plan is coherent and the strategic logic defensible. But with impairments, provisions, and job cuts all landing in the same window, Lenzing remains a restructuring story with an unresolved ending. The doubled profit may have bought the company time; whether it buys the company trust is a different matter entirely.
